Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms.
about
Are We in the Same Risk of Diabetes Mellitus? Gender- and Age-Specific Epidemiology of Diabetes in 2001 to 2014 in the Korean PopulationImproved prediction of complex diseases by common genetic markers: state of the art and further perspectivesGenetic prediction of common diseases. Still no help for the clinical diabetologist!Genetic screening for the risk of type 2 diabetes: worthless or valuable?Is genetic testing useful to predict type 2 diabetes?Insights into the genetic basis of type 2 diabetesThe study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetesAssociation of a 62 Variants Type 2 Diabetes Genetic Risk Score With Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter Study.Methylation array data can simultaneously identify individuals and convey protected health information: an unrecognized ethical concern.Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application.Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort studyPolygenic type 2 diabetes prediction at the limit of common variant detectionAssociation of African genetic ancestry with fasting glucose and HbA1c levels in non-diabetic individuals: the Boston Area Community Health (BACH) Prediabetes Study.Susceptibility to type 2 diabetes mellitus--from genes to preventionGenetic risk profiling for prediction of type 2 diabetesMetabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes.Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and designGenetic predisposition to higher body mass index or type 2 diabetes and leukocyte telomere length in the Nurses' Health Study.TCF7L2 is a master regulator of insulin production and processing.Despite Underestimated Familial Risk by Self-Report, Family History Correlates with Perceived Risk and Worry about Chronic Diseases Such as Coronary Heart Disease and Diabetes.Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes.Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program.The value of genetic information for diabetes risk prediction - differences according to sex, age, family history and obesity.Association between parental history of diabetes and type 2 diabetes genetic risk scores in the PPP-Botnia and Framingham Offspring Studies.A methodological perspective on genetic risk prediction studies in type 2 diabetes: recommendations for future research.Advances in risk prediction of type 2 diabetes: integrating genetic scores with Framingham risk models.Sixty-five common genetic variants and prediction of type 2 diabetesGenetic Testing and Type 2 Diabetes Risk Awareness.Genetics of Type 2 Diabetes and Clinical Utility.A comparison of time dependent Cox regression, pooled logistic regression and cross sectional pooling with simulations and an application to the Framingham Heart Study.Does Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of Veterans.A genotype risk score predicts type 2 diabetes from young adulthood: the CARDIA study.Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications.Genotype prediction of adult type 2 diabetes from adolescence in a multiracial population.What will diabetes genomes tell us?Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review.Novel risk factors and the prediction of type 2 diabetes in the Atherosclerosis Risk in Communities (ARIC) study.Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial.The new perspectives on genetic studies of type 2 diabetes and thyroid diseasesGene-environment and gene-treatment interactions in type 2 diabetes: progress, pitfalls, and prospects
P2860
Q26748139-56B15121-9EB2-471C-9AFB-702203557801Q26770167-F48BC7D4-F501-4184-B8F5-07406EEF2775Q26822607-3FA4C923-1B12-4FBC-B932-62798616DDE9Q26829897-465C21EF-75AD-4E21-90A1-E494C6A2EF18Q26859442-C008A17F-FD8D-40D2-93B1-2AFB66580773Q26859885-424B459A-A42E-4924-9507-374DA6038989Q28545045-88B561A6-71AF-4ED1-8ACB-1D5EB29DF01CQ30358502-9858DA75-3400-4428-96EF-20526C305CB7Q30928890-572E45B5-053C-4102-8F66-651384993FAEQ33593963-5D7BD6FB-F51D-4A7E-AC71-8C527637221CQ33638105-D2B1CD79-A119-4ED2-82C7-174188375D57Q33646775-9E5D5644-0E50-4095-ACB6-E417D3345DE5Q33656987-BA9F47CD-513D-42D1-8A49-1618E471BD6BQ33759253-3F8A0C83-2F03-45F7-A52E-5EFEE6D453E8Q33807014-E382E337-4011-4767-AACE-F57A5CC0BE8FQ34073453-E2318B6D-8860-4693-8CB0-DE2AEC0920CBQ34132349-B8EC931A-00FD-49D8-8F8D-7BC7700BEE9CQ34328685-49354FB8-D109-484A-9ABC-B908FE156C9BQ34555421-7C0517CD-0A79-4393-99DD-29EFB88BB51BQ34577672-63C21C6F-473A-4E91-A565-9549FDC83090Q34583225-07D954AE-7E0F-4335-9678-D25DC684B77BQ34718943-487747C8-D119-4474-896F-F0F0BF3861D0Q34735432-669703AE-BA58-4FCB-A639-04998F5D273AQ35165236-95CE8B31-2E23-40B0-8785-936A7269CAE2Q35512242-5BCBC3C5-1428-471B-BD38-58C579666513Q35532280-B241BD0D-88E6-4C68-84E6-529AE05BDE9BQ35532317-587FC11F-5ADD-4573-A1E7-942A9387983EQ35761568-78A42C5B-EC8F-473E-838A-399D18A24BDCQ35808509-67398B57-A80E-460D-8B76-A05D0CBBAF27Q36181347-028C7627-B57A-45E1-9554-8486C3CE9001Q36199476-B49F84ED-00DD-4164-B9D5-53D1CFC56691Q36210172-5547BB66-F98C-4CFF-BABF-9E097335DC9BQ36250613-8D6BA810-1027-4B6C-B4C0-86234B9203D3Q36355974-F4706947-38B3-4E77-AB48-708D4DA10106Q36374101-3A0973D8-C42E-4434-B1CB-C10C55DBDBFBQ36384522-E3A1B2D4-C0B7-49D9-92C9-925DC30F8B25Q36477823-FCCF710B-3F37-4A72-9B7E-BF6A4334972EQ36477848-49134C79-FD6D-4DCA-8E92-6B349663BC4DQ36634117-C3352F10-457F-41FE-B565-A5F676BC4C93Q36782845-A85C6BB1-E42B-4DF8-BBF8-D8896828FA36
P2860
Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genetic risk reclassification ...... ngle nucleotide polymorphisms.
@ast
Genetic risk reclassification ...... ngle nucleotide polymorphisms.
@en
Genetic risk reclassification ...... ngle nucleotide polymorphisms.
@nl
type
label
Genetic risk reclassification ...... ngle nucleotide polymorphisms.
@ast
Genetic risk reclassification ...... ngle nucleotide polymorphisms.
@en
Genetic risk reclassification ...... ngle nucleotide polymorphisms.
@nl
prefLabel
Genetic risk reclassification ...... ngle nucleotide polymorphisms.
@ast
Genetic risk reclassification ...... ngle nucleotide polymorphisms.
@en
Genetic risk reclassification ...... ngle nucleotide polymorphisms.
@nl
P2093
P2860
P50
P356
P1433
P1476
Genetic risk reclassification ...... ingle nucleotide polymorphisms
@en
P2093
Alisa K Manning
Caroline S Fox
DIAGRAM+ Investigators
James B Meigs
Jose C Florez
MAGIC Investigators
Michael J Pencina
Peter Shrader
Ralph B D'Agostino
P2860
P304
P356
10.2337/DC10-1265
P407
P577
2010-10-01T00:00:00Z